Delivery Order SPE2DB22D2218-SPE2DB24FR2BY
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,125,413 units of the prescription drug Ondansetron ODT 8mg Tablet. The contract, valued at $1,189.99, has an ultimate completion date of April 1, 2024. As the prime contractor, Amerisourcebergen Drug Corp will deliver these pharmaceutical products from its Corporate Office in Conshohocken, Pennsylvania to support...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,728,753 units of Ondansetron ODT 8 mg tablets. The $3,297.64 contract has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under an indefinite delivery contract (IDC) valued up...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,249,283 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet 30s. The award, valued at $6,719.95, has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,235,087 units of Ondansetron ODT 4 mg tablets. The $4,464.67 contract has an ultimate completion date of April 11, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp is the prime contractor and serves as the primary supplier of pharmaceutical products and medical supplies to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,635,055 units of the pharmaceutical product Ondansetron ODT 4 MG Tablet 30S. The contract has a potential value of $5,262.72 and a completion date of February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. Amerisourcebergen...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,643,171 units of Ondansetron ODT 8 mg tablets in 30-count packages. The $2,239.95 contract has a completion date of February 14, 2024 and was awarded on February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is part of a...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $1,734.42 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ondansetron ODT 8 mg tablets. The contract has a completion date of January 26, 2024 and was awarded on January 25, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,152,895 units of Ondansetron ODT 8 mg tablets in 30-count packages. The $8,832.72 order has a completion date of December 21, 2023 and was awarded on December 20, 2023. AmerisourceBergen Drug Corp, operating out of its corporate office in Conshohocken, Pennsylvania, is a prime contractor that regularly supplies...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,563,581,852 units of Ondansetron ODT 4 mg tablets to Conshohocken, Pennsylvania, with a completion date of February 8, 2024 and a potential value of $1,553.58. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DLA and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide 4,563,971,285 units of the medication Ondansetron ODT 4 mg Tablet. The $24,983.87 contract has a performance period through March 15, 2024. Amerisourcebergen Drug Corp serves as a prime contractor for DLA, providing a wide range of pharmaceutical products and medical supplies...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB24FR2BYDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,755,841 units of the pharmaceutical product Ondansetron ODT 8 MG Tablet. The contract has a completion date of February 26, 2024, a potential value of $2,677.53, and was not subject to any set-aside requirements. Amerisourcebergen Drug Corp, as the prime contractor, will deliver these pharmaceutical supplies from its corporate office located in Conshohocken, Pennsylvania to support military treatment programs and facilities under the purview of the Department of Defense. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 2/23/24 |